These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27890544)

  • 1. Persistent hydrocephalus due to postural activation of a ventricular shunt anti-gravity device.
    Craven CL; Toma AK; Watkins LD
    J Clin Neurosci; 2017 Mar; 37():91-95. PubMed ID: 27890544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gravitational shunt units may cause under-drainage in bedridden patients.
    Kaestner S; Kruschat T; Nitzsche N; Deinsberger W
    Acta Neurochir (Wien); 2009 Mar; 151(3):217-21; discussion 221. PubMed ID: 19238319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-low-pressure hydrocephalic state in NPH: benefits of therapeutic siphoning with adjustable antigravity valves.
    Funnell JP; D'Antona L; Craven CL; Thorne L; Watkins LD; Toma AK
    Acta Neurochir (Wien); 2020 Dec; 162(12):2967-2974. PubMed ID: 32989519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with a dual switch valve (Miethke) for the management of adult hydrocephalus.
    Tsunoda A; Maruki C
    Neurol Med Chir (Tokyo); 2007 Sep; 47(9):403-8; discussion 408. PubMed ID: 17895613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro performance of the fixed and adjustable gravity-assisted unit with and without motion-evidence of motion-induced flow.
    Kimura T; Schulz M; Shimoji K; Miyajima M; Arai H; Thomale UW
    Acta Neurochir (Wien); 2016 Oct; 158(10):2011-8. PubMed ID: 27553048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro performance of six combinations of adjustable differential pressure valves and fixed anti-siphon devices with and without vertical motion.
    Fiss I; Röhrig P; Hore N; von der Brelie C; Bettag C; Freimann FB; Thomale UW; Rohde V; Brandner S
    Acta Neurochir (Wien); 2020 Oct; 162(10):2421-2430. PubMed ID: 32779025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the Miethke programmable differential pressure valve (proGAV®2.0): a single-centre retrospective analysis.
    Hall BJ; S Gillespie C; Hennigan D; Bagga V; Mallucci C; Pettorini B
    Childs Nerv Syst; 2021 Aug; 37(8):2605-2612. PubMed ID: 34021371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gravitational shunt complications after a five-year follow-up.
    Kiefer M; Eymann R
    Acta Neurochir Suppl; 2010; 106():107-12. PubMed ID: 19812930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The applicability of fixed and adjustable gravitational shunt valves in two different clinical settings.
    Månsson PK; Hansen TS; Juhler M
    Acta Neurochir (Wien); 2018 Jul; 160(7):1415-1423. PubMed ID: 29804178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Miethke dual switch valve: experience in 169 adult patients with different kinds of hydrocephalus: an open field study.
    Hertel F; Züchner M; Decker C; Schill S; Bosniak I; Bettag M
    Minim Invasive Neurosurg; 2008 Jun; 51(3):147-53. PubMed ID: 18521785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of programmable compared with fixed anti-siphon devices for treating idiopathic normal-pressure hydrocephalus (iNPH) in adults - SYGRAVA: study protocol for a randomized trial.
    Scholz R; Lemcke J; Meier U; Stengel D
    Trials; 2018 Oct; 19(1):566. PubMed ID: 30333067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adjustable gravitational valve for initial VP-shunt treatment in hydrocephalic preterm neonates and infants below 1 year of age.
    Bock HC; von Philipp G; Ludwig HC
    Childs Nerv Syst; 2021 Nov; 37(11):3497-3507. PubMed ID: 34152450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ventriculo-gallbladder shunt in the treatment of refractory hydrocephalus: a review of the current literature.
    Girotti ME; Singh RR; Rodgers BM
    Am Surg; 2009 Aug; 75(8):734-7. PubMed ID: 19725301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus.
    Izci Y; Secer H; Akay C; Gonul E
    Neurol Res; 2009 Apr; 31(3):234-7. PubMed ID: 19040800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gravitational valves in supine patients with ventriculo-peritoneal shunts.
    Deininger MH; Weyerbrock A
    Acta Neurochir (Wien); 2009 Jun; 151(6):705-9; discussion 709. PubMed ID: 19337679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of valve type and poor ventricular catheter placement: Modifiable factors associated with ventriculoperitoneal shunt failure.
    Jeremiah KJ; Cherry CL; Wan KR; Toy JA; Wolfe R; Danks RA
    J Clin Neurosci; 2016 May; 27():95-8. PubMed ID: 26758704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous-flow shunt for treatment of hydrocephalus due to lesions of the posterior fossa.
    Arriada N; Sotelo J
    J Neurosurg; 2004 Nov; 101(5):762-6. PubMed ID: 15540913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postshunt insertion CSF leaks in infants treated by an adjustable valve opening pressure reduction.
    Rohde V; Weinzierl M; Mayfrank L; Gilsbach JM
    Childs Nerv Syst; 2002 Dec; 18(12):702-4. PubMed ID: 12483354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the proGAV shunt valve in normal-pressure hydrocephalus.
    Toma AK; Tarnaris A; Kitchen ND; Watkins LD
    Neurosurgery; 2011 Jun; 68(2 Suppl Operative):245-9. PubMed ID: 21368692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a nonintermediate-incision ventriculoperitoneal shunt procedure using a nasogastric feeding tube for infant patients with hydrocephalus: technical note.
    Hamauchi S; Seki T; Sasamori T; Houkin K
    J Neurosurg Pediatr; 2016 May; 17(5):540-3. PubMed ID: 26722867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.